Pseudomonas Vaccine Development
Immunization against Pseudomonas aeruginosa reviewed
Published in Vaccine Weekly, October 5th, 2005
According to a study from Australia, "Pseudomonas aeruginosa remains a serious pathogen for specific cohorts of patients where chronic infection is a poor prognostic indicator, such as those with cystic fibrosis, burn wounds, or those who are immunocompromised. Significant disease burden is associated with a diverse spectrum of both nosocomial and community-acquired infections."
"To date, vaccines against P. aeruginosa have shown limited and often conflicting efficacy data, especially against...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-10-05)
More Articles from Vaccine Weekly
- Avian Influenza
Methods to contain pandemic influenza at the source examined - Melanoma Vaccine Development
Protection against melanoma found without autoimmune depigmentation - Tuberculosis Vaccine Development
Variant tricarboxylic acid cycle found in M. tuberculosis - Vaccine Adjuvant
Role of adjuvants in development of mucosal vaccines reviewed - Vaccine Efficacy
QPCR used to assign infectious potencies to adenovirus-based vaccines - Addiction Medicine
Drug users in Ireland remain vulnerable to bloodborne pathogens - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
